Despite appearing successful on scans, radiotherapy may leave behind undetected microscopic cancer cells, posing a greater ...

Radiotherapy, especially a form known as stereotactic ablative radiotherapy (SABR), is widely used to treat cancers in the ...

Radiotherapy may leave behind microscopic cancer even when scan images suggest the tumour is gone, and this“residual diseas ...

Residual cancer can remain undetected despite clear scans, potentially leading to worse outcomes and higher risks of ...

While radiotherapy is a highly effective cancer treatment -- useful for about 60 per cent of all cancers -- it may lead to ...

"Residual cancer is identified on histology in 40% of lung, 57–69% of renal cell, 7.7–47.6% of prostate and 0–86.7% of hepatocellular carcinoma." ...

BUFFALO, NY - March 21, 2025 – A new editorial was published in Oncotarget, Volume 16, on March 13, 2025, titled “ No disease ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

HealthDay News — For patients with chronic liver disease, statin use is associated with a reduced risk for hepatocellular carcinoma (HCC) and hepatic decompensation, according to a study published ...

The FDA has issued a complete response letter for rivoceranib plus camrelizumab as a first-line treatment for unresectable ...

An expert discusses how, for advanced unresectable hepatocellular carcinoma (uHCC), clinicians monitor treatment efficacy ...